Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osnat Ashur-Fabian

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Cell Cycle (Georgetown, Tex.)|August 13, 2010
The expression of p53-target genes in the hypoxia-tolerant subterranean mole-rat is hypoxia-dependent and similar to expression patterns in solid tumorsMark Band, Osnat Ashur-Fabian, Aaron Avivi
Oncogene|March 16, 2019
Targeting the Achilles' heel of cancer cells via integrin-mediated delivery of ROS-generating dihydrolipoamide dehydrogenaseAvraham Dayan, Gideon Fleminger, Osnat Ashur-Fabian
RSC Advances|May 11, 2022
RGD-modified dihydrolipoamide dehydrogenase conjugated to titanium dioxide nanoparticles - <b>switchable</b> integrin-targeted photodynamic treatment of melanoma cellsAvraham Dayan, Gideon Fleminger, Osnat Ashur-Fabian
Oncotarget|August 25, 2016
The double benefit of Spalax p53: surviving underground hypoxia while defying lung cancer cells in vitro via autophagy and caspase-dependent cell deathMartin Ellis, Orly Stern, Osnat Ashur-Fabian
Current Opinion in Endocrinology, Diabetes, and Obesity|August 7, 2010
Thyroid hormones and cancer: clinical studies of hypothyroidism in oncologyAleck H Hercbergs, Osnat Ashur-Fabian, David Garfield
Frontiers in Endocrinology|March 1, 2019
Thyroid Hormones and Cancer: A Comprehensive Review of Preclinical and Clinical StudiesEilon Krashin, Agnieszka Piekiełko-Witkowska, Martin Ellis, et al.
The Israel Medical Association Journal : IMAJ|January 12, 2007
A clonal hypereosinophilic syndrome with specific and effective therapy: a report of two casesMartin H Ellis, Osnat Ashur-Fabian, Luba Trakhtenbrot, et al.
Cell Cycle (Georgetown, Tex.)|February 11, 2005
p53--a key player in tumoral and evolutionary adaptation: a lesson from the Israeli blind subterranean mole ratAaron Avivi, Osnat Ashur-Fabian, Ninette Amariglio, et al.
Journal of the National Cancer Institute|February 1, 2012
Re: Thyroid dysfunction from antineoplastic agentsAleck A Hercbergs, David Garfield, Osnat Ashur-Fabian, et al.
Frontiers in Endocrinology|December 24, 2019
Editorial: Non Genomic Actions of Thyroid Hormones in CancerPaul J Davis, Osnat Ashur-Fabian, Sandra Incerpi, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Cell Cycle (Georgetown, Tex.)|August 13, 2010
The expression of p53-target genes in the hypoxia-tolerant subterranean mole-rat is hypoxia-dependent and similar to expression patterns in solid tumorsMark Band, Osnat Ashur-Fabian, Aaron Avivi
Oncogene|March 16, 2019
Targeting the Achilles' heel of cancer cells via integrin-mediated delivery of ROS-generating dihydrolipoamide dehydrogenaseAvraham Dayan, Gideon Fleminger, Osnat Ashur-Fabian
RSC Advances|May 11, 2022
RGD-modified dihydrolipoamide dehydrogenase conjugated to titanium dioxide nanoparticles - <b>switchable</b> integrin-targeted photodynamic treatment of melanoma cellsAvraham Dayan, Gideon Fleminger, Osnat Ashur-Fabian
Oncotarget|August 25, 2016
The double benefit of Spalax p53: surviving underground hypoxia while defying lung cancer cells in vitro via autophagy and caspase-dependent cell deathMartin Ellis, Orly Stern, Osnat Ashur-Fabian
Current Opinion in Endocrinology, Diabetes, and Obesity|August 7, 2010
Thyroid hormones and cancer: clinical studies of hypothyroidism in oncologyAleck H Hercbergs, Osnat Ashur-Fabian, David Garfield
Frontiers in Endocrinology|March 1, 2019
Thyroid Hormones and Cancer: A Comprehensive Review of Preclinical and Clinical StudiesEilon Krashin, Agnieszka Piekiełko-Witkowska, Martin Ellis, et al.
The Israel Medical Association Journal : IMAJ|January 12, 2007
A clonal hypereosinophilic syndrome with specific and effective therapy: a report of two casesMartin H Ellis, Osnat Ashur-Fabian, Luba Trakhtenbrot, et al.
Cell Cycle (Georgetown, Tex.)|February 11, 2005
p53--a key player in tumoral and evolutionary adaptation: a lesson from the Israeli blind subterranean mole ratAaron Avivi, Osnat Ashur-Fabian, Ninette Amariglio, et al.
Journal of the National Cancer Institute|February 1, 2012
Re: Thyroid dysfunction from antineoplastic agentsAleck A Hercbergs, David Garfield, Osnat Ashur-Fabian, et al.
Frontiers in Endocrinology|December 24, 2019
Editorial: Non Genomic Actions of Thyroid Hormones in CancerPaul J Davis, Osnat Ashur-Fabian, Sandra Incerpi, et al.
Pageof 6